Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37085487.
- Also identified by DOI 10.1038/s41467-023-38026-2 and PMC identifier 10121561.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The type-1 cannabinoid receptor (CB<sub>1</sub>R) is widely expressed in excitatory and inhibitory nerve terminals, and by suppressing neurotransmitter release, its activation modulates neural circuits and brain function. While the interaction of CB<sub>1</sub>R with various intracellular proteins is thought to alter receptor signaling, the identity and role of these proteins are poorly understood. Using a high-throughput proteomic analysis complemented with an array of in vitro and in vivo approaches in the mouse brain, we report that the C-terminal, intracellular domain of CB<sub>1</sub>R interacts specifically with growth-associated protein of 43 kDa (GAP43). The CB<sub>1</sub>R-GAP43 interaction occurs selectively at mossy cell axon boutons, which establish excitatory synapses with dentate granule cells in the hippocampus. This interaction impairs CB<sub>1</sub>R-mediated suppression of mossy cell to granule cell transmission, thereby inhibiting cannabinoid-mediated anti-convulsant activity in mice. Thus, GAP43 acts as a synapse type-specific regulatory partner of CB<sub>1</sub>R that hampers CB<sub>1</sub>R-mediated effects on hippocampal circuit function.
Medical subject headings
- Cannabinoids